We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Novel Biomaterial Protects Tissues Against Harmful Radiation

By MedImaging International staff writers
Posted on 23 Jul 2020
Print article
Image: Human cells treated with Selenomelanin nanoparticles (Photo courtesy of NU)
Image: Human cells treated with Selenomelanin nanoparticles (Photo courtesy of NU)
A synthesized form of melanin enriched with selenium could shield human tissues from X-rays during medical treatment or spaceflight, according to a new study.

Developed at Northwestern University (NU; Evanston, IL, USA), the University of California, San Diego (UCSD; USA), and other institutions, the new material is called Selenomelanin, and is an analogue of pheomelanin (the pigment responsible for red hair, which contains sulfur), that has been shown to absorb X-rays more efficiently than the more common eumelanin, which gives black and brown hair their color. The researchers hypothesized that enriching pheomelanin with selenium instead of sulfur would provide better protection against X-rays.

After synthesizing Selenomelanin, they then used it to treat neonatal human epidermal keratinocytes (NHEK); for comparison, they prepared cells treated with synthetic pheomelanin and eumelanin, as well as cells with no protective melanin at all. All cells were subjected to high-dose X-ray irradiation, at levels that would be lethal to a human being. They found that only those cells treated with Selenomelanin still exhibited a normal cell cycle, and did not undergo G2/M phase arrest. The study was published on July 8, 2020, in the Journal of the American Chemical Society (JACS).

“Melanin may act as a repository for selenium, helping ensure that organisms benefit from it. Our results demonstrated that selenomelanin offers superior protection from radiation,” said senior author Nathan Gianneschi, PhD, of NU. “We also found that it was easier to synthesize selenomelanin than pheomelanin, and what we created was closer than synthetic pheomelanin to the melanin found in nature. Selenomelanin may play an important role in how selenium is metabolized and distributed biologically. It's an area for further investigation.”

Melanins are a family of heterogeneous biopolymers found ubiquitously across plant, animal, bacterial, and fungal kingdoms where they act variously as pigments and as radiation protection agents. There exist five multifunctional, structurally and biosynthetically incompletely understood varieties of melanin: eumelanin, neuromelanin, pyomelanin, allomelanin, and pheomelanin.

Related Links:
Northwestern University
University of California, San Diego


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Brachytherapy Planning System
Oncentra Brachy
New
Ultrasound System
P20 Elite
New
Breast Imaging Workstation
SecurView

Print article
Radcal

Channels

MRI

view channel
Image: The emerging role of MRI alongside PSA testing is redefining prostate cancer diagnostics (Photo courtesy of 123RF)

Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients

Prostate cancer is a leading health concern globally, consistently being one of the most common types of cancer among men and a major cause of cancer-related deaths. In the United States, it is the most... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.